![]() |
市场调查报告书
商品编码
1859896
医用导管:全球市场份额和排名、总销售额和需求预测(2025-2031 年)Medical Catheters - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
全球医用导管市场预计在 2024 年达到 308.55 亿美元,预计到 2031 年将达到 452.38 亿美元,2025 年至 2031 年的复合年增长率为 5.7%。
本报告对近期关税调整和国际策略反制措施对医用导管跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组的影响进行了全面评估。
医用导管是一种插入人体、体腔或血管的医疗设备,用于输注液体或药物、排放液体、监测生理参数或提供路径。依应用领域划分,医用导管可分为心血管导管、泌尿系统、神经血管导管、静脉导管和特殊用途导管。依材料划分,医用导管可分为硅胶导管、聚氨酯(PU)导管、聚氯乙烯(PVC)导管、氟聚合物导管和高性能医用聚合物导管。依使用时间和置入方式划分,医用导管可进一步分为短期一次性导管和长期留置导管。医用导管在微创手术、透析、泌尿系统管理、介入性介入心臟病学、加护治疗和居家医疗中至关重要。关键设计要求包括生物相容性、耐化学性、柔韧性和抗菌性能,在某些情况下,还需要整合可视化和感测器。预计2024年,全球医用导管产量将达到约61.77亿支,全球平均市场价格约为每支5美元。
目前,医用导管产业正处于快速成长阶段,多种驱动因素为执行长、市场经理和投资者提供了明确的机会。首先,全球慢性心血管疾病、泌尿系统、肾臟疾病和神经系统疾病的发生率持续上升,为用于诊断和治疗的导管产品创造了稳定且不断增长的需求基础。其次,人口老化显着增加了泌尿系统管理、长期静脉通路和透析等领域对导管的需求。第三,医疗技术创新(尤其是微创手术、干涉导管以及整合可视化和感测器的导管)为高附加价值和差异化提供了机会。第四,医疗费用支出不断增长、保险报销政策不断扩大以及公共卫生投资不断增加,提高了高性能和功能性导管的接受度,并降低了部分地区的市场准入门槛。第五,对感染控制、一次性或涂层导管以及可生物降解或环保材料的监管和环境要求不断提高,创造了新的需求成长点。这些因素综合起来,为医疗导管市场在产品类型、材料复杂性、服务扩展(居家医疗、远端医疗)和地理扩展(新兴市场)方面提供了巨大的成长空间。
儘管医疗导管产业蕴藏着许多机会,但也面临严峻的挑战与风险。首先,感染风险和导管相关併发症(例如,导管相关性尿道感染和中央静脉导管相关性血流感染疾病)仍然是主要的临床问题。除非产品能够透过涂层、灭菌和设计(一次性使用与可重复使用)显着降低风险,否则其市场信誉和监管核准可能会受到限制。其次,高端导管产品高成本,需要大量的研发投入,并涉及复杂的材料和製造流程。某些市场对价格的敏感度以及高端和新型技术导管缺乏报销机制可能会限制其普及。第三,监管和品质标准不断加强。生物相容性、毒性、物理性能、灭菌验证、註册和核准的要求日益严格,尤其是在已开发国家和欧盟。这些监管流程耗时且高成本,为中小企业带来了沉重的负担。第四,原料价格波动和供应不稳定(尤其是高性能聚合物、特殊涂料和进口材料)对成本结构和前置作业时间有显着影响。第五,新兴市场虽然提供了快速成长的机会,但也面临着基础设施不足、外科和介入人员技能水平有限、报销体系缓慢以及采购结构分散等挑战,导致市场进入和规模扩张速度较慢,且资本投入更高。
在下游临床和终端使用者层面,医用导管的结构和功能需求正在不断演变。首先,医院和介入手术中心越来越需要微创、快速更换以及导航或影像引导的导管,以缩短手术时间、减少病患创伤并提高操作者的灵活性。其次,居家医疗和远端医疗环境越来越需要一次性导管、可自行导尿、易于使用且维护成本低的导管,患者的舒适度和卫生状况也成为关键的产品差异化因素。第三,对连结性和智慧功能的需求日益增长。具备感测功能、压力监测、温度和流量回馈、进阶视觉化以及与数位医疗系统整合等特性的导管正成为优先考虑的因素。第四,日益增长的环境和永续性问题推动了对可生物降解材料、不含邻苯二甲酸二辛酯(DEHP)、不含乳胶或低过敏性材料、减少废弃物以及可回收包装的需求,这些正日益成为关键的采购标准。第五,下游采购管道在不同地区也在改变。已开发经济体正在走向集中采购、报销和标准化竞标系统,而新兴市场正在透过公私合营、政策主导的公共医疗设施扩张、门诊手术中心 (ASC)、居家医疗以及电子商务管道日益增长的重要性,重塑需求到达製造商的方式。
医用导管的上游原料主要包括医用聚合物(硅胶、聚氨酯(PU)、聚氯乙烯(PVC)、氟聚合物以及更先进的医用塑料,例如聚醚醚酮(PEEK)和医用级聚砜)、被覆剂和抗菌剂(银涂层、抗生物膜涂层、亲水/滑动涂层)、金属组件(例如导管包装器和某些连接器的连接管)。每种材料类别都有不同的市场特性和相关风险。该产品的平均毛利率为52%。
本报告旨在按地区/国家、类型和应用对全球医用导管市场进行全面分析,重点关注总销售量、收入、价格、市场份额和主要企业的排名。
医疗导管市场规模、估算和预测以销售(百万)和收入(百万美元)为单位呈现,基准年为2024年,并包含2020年至2031年的历史数据和预测数据。定量和定性分析将帮助读者制定医疗导管业务和成长策略,评估市场竞争,分析自身在当前市场中的地位,并做出明智的商业决策。
市场区隔
公司
按类型分類的细分市场
应用领域
按地区
The global market for Medical Catheters was estimated to be worth US$ 30855 million in 2024 and is forecast to a readjusted size of US$ 45238 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Medical Catheters cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Medical catheters are medical devices inserted into the human body or body cavities or vessels to deliver fluids or medications, drain body fluids, monitor physiological parameters, or provide access channels. They are classified by use into cardiovascular, urological, neurovascular, intravenous, and specialty catheters; by materials such as silicone, polyurethane (PU), polyvinyl chloride (PVC), fluoropolymers, or high-performance medical polymers; and by duration or implantation mode into short-term disposable vs. long-term implanted types. They are essential in contexts such as minimally invasive surgeries, dialysis, urinary management, cardiovascular interventions, critical care, and home healthcare. Key design requirements include biocompatibility, chemical resistance, flexibility, antimicrobial properties, and in some cases visualization or sensor integration.In 2024, global Medical catheters production reached approximately 6177 m units, with an average global market price of around US$ 5 perunit.
The medical catheter industry is currently in a rapid growth phase, with multiple driving forces presenting clear opportunities for CEOs, marketing managers, and investors. First, the global incidence of chronic cardiovascular diseases, urinary and renal disorders, and neurological conditions continues to rise, creating a stable and expanding demand base for catheter products used in diagnosis and treatment. Second, demographic aging significantly increases catheter needs in areas such as urinary management, long-term venous access, and dialysis. Third, innovation in medical technologies-especially minimally invasive surgery, interventional catheterization, visualization-enabled and sensor-integrated catheters-offers high value-add and differentiation opportunities. Fourth, rising healthcare expenditure, enhanced insurance reimbursement policies, and public health investment are improving acceptance of premium and functional catheters, lowering entry barriers in some regions. Fifth, increasing regulatory and environmental demands for infection control, disposable or coated catheters, and biodegradable or low environmental-impact materials are creating new demand growth points. Combined, these factors make the medical catheter market fertile for expansion across product types, material upgrades, service extension (home care, telemedicine), and geographic reach (emerging markets).
While numerous opportunities exist, the medical catheter industry faces significant challenges and risks. First, infection risk and catheter-related complications (such as catheter-associated urinary tract infections, central line-associated bloodstream infections) remain major clinical concerns; unless products meaningfully reduce risk via coatings, sterilization, and design (disposable vs reusable), market reputation and regulatory approvals may be constrained. Second, high-end catheter products have high costs, require large R&D investment, and involve complex materials and manufacturing processes; pricing sensitivity in some markets, and lack of reimbursement for premium or novel technology catheters, may suppress adoption. Third, regulations and quality standards are continually rising-biocompatibility, toxicity, physical performance, sterilization validation, registration and approval are increasingly stringent-especially in developed economies and the EU; these regulatory pathways are long and expensive, putting pressure especially on small and medium firms. Fourth, raw material price volatility and supply instability-especially for high-performance polymers, specialized coatings, or imported materials-significantly affect cost structure and lead times. Fifth, although emerging markets offer fast growth, they often suffer from differences in infrastructure, skill level of surgical or interventional staff, lagging reimbursement systems, decentralized procurement, etc., which make market entry and scaling slower and more capital-intensive.
At the downstream clinical and end-user side, demand is undergoing structural and functional evolution in requirements for medical catheters. First, hospitals and interventional surgery centers are increasingly demanding minimally invasive catheters, quick-exchange types, navigation or imaging-guided catheters to reduce operating time, lower invasiveness for patients, and increase operator flexibility. Second, in home care and telemedicine settings, demand is growing for disposable catheters, self-catheterization, ease of use, low maintenance devices; patient comfort and hygiene have become key product differentiators. Third, connectivity and smart features are rising: catheters with sensing functions, pressure monitoring, temperature or flow feedback, visualized tips, and integration with digital health systems are being more prioritized. Fourth, environmental and sustainability concerns are pushing demand toward biodegradable materials, DEHP-free, latex-free or low allergen materials, reduced waste and recyclable packaging, which increasingly become procurement criteria. Fifth, regional downstream procurement channels are evolving: in developed countries, centralized purchasing, insurance reimbursement and standardized tendering systems are maturing; in emerging markets, public-private partnerships, policy-driven public health facility expansion, and increasing importance of outpatient surgery centers (ASCs), home care, and even e-commerce channels are reshaping how demand reaches manufacturers.
The upstream raw materials for medical catheters mainly include medical polymers (such as silicone, polyurethane (PU), PVC, fluoropolymers, and more advanced medical plastics like PEEK or medical-grade polysulfone), coating and antimicrobial agents (silver coatings, anti-biofilm coatings, hydrophilic/slip coatings), metallic components (in tips, support scaffolds or electrode parts of certain catheters), and auxiliary & packaging materials (sterile packaging, connectors, sealing components). Each material category exhibits distinct market characteristics and associated risks. The average gross profit margin of this product is 52%
This report aims to provide a comprehensive presentation of the global market for Medical Catheters, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Medical Catheters by region & country, by Type, and by Application.
The Medical Catheters market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Catheters.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Catheters manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Medical Catheters in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Medical Catheters in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.